Vaxxinity Stock Fundamentals
| VAXXDelisted Stock | USD 2.72 0.19 6.53% |
Vaxxinity fundamentals help investors to digest information that contributes to Vaxxinity's financial success or failures. It also enables traders to predict the movement of Vaxxinity Pink Sheet. The fundamental analysis module provides a way to measure Vaxxinity's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vaxxinity pink sheet.
Vaxxinity |
Vaxxinity Company Return On Equity Analysis
Vaxxinity's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Vaxxinity Return On Equity | -1.51 |
Most of Vaxxinity's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vaxxinity is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Vaxxinity has a Return On Equity of -1.5065. This is 93.72% lower than that of the Biotechnology sector and 95.87% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Vaxxinity Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Vaxxinity's current stock value. Our valuation model uses many indicators to compare Vaxxinity value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Vaxxinity competition to find correlations between indicators driving Vaxxinity's intrinsic value. More Info.Vaxxinity is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Vaxxinity by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Vaxxinity's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Vaxxinity Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vaxxinity's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Vaxxinity could also be used in its relative valuation, which is a method of valuing Vaxxinity by comparing valuation metrics of similar companies.Vaxxinity is currently under evaluation in return on equity category among its peers.
Vaxxinity Fundamentals
| Return On Equity | -1.51 | ||||
| Return On Asset | -0.48 | ||||
| Current Valuation | (1.39 M) | ||||
| Shares Outstanding | 112.91 M | ||||
| Shares Owned By Insiders | 50.90 % | ||||
| Shares Owned By Institutions | 12.24 % | ||||
| Number Of Shares Shorted | 4.22 M | ||||
| Price To Book | 4.58 X | ||||
| Price To Sales | 4,605 X | ||||
| Gross Profit | (1.87 M) | ||||
| EBITDA | (56.05 M) | ||||
| Net Income | (56.93 M) | ||||
| Cash And Equivalents | 128.23 M | ||||
| Cash Per Share | 1.02 X | ||||
| Total Debt | 15.17 M | ||||
| Debt To Equity | 0.09 % | ||||
| Current Ratio | 5.46 X | ||||
| Book Value Per Share | 0.11 X | ||||
| Cash Flow From Operations | (57.24 M) | ||||
| Short Ratio | 13.97 X | ||||
| Earnings Per Share | (0.45) X | ||||
| Price To Earnings To Growth | 0.05 X | ||||
| Target Price | 15.0 | ||||
| Number Of Employees | 57 | ||||
| Beta | 2.4 | ||||
| Market Capitalization | 14.09 M | ||||
| Total Asset | 44.35 M | ||||
| Retained Earnings | (361.64 M) | ||||
| Working Capital | 15.62 M | ||||
| Net Asset | 44.35 M |
About Vaxxinity Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vaxxinity's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vaxxinity using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vaxxinity based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. Vaxxinity, Inc. was founded in 2014 and is headquartered in Dallas, Texas. Vaxxinity Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 89 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Consideration for investing in Vaxxinity Pink Sheet
If you are still planning to invest in Vaxxinity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vaxxinity's history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |